US health officials explore banning some SSRI antidepressants
Updated
Updated · Reuters · May 8
US health officials explore banning some SSRI antidepressants
10 articles · Updated · Reuters · May 8
The discussions last week involved long-used drugs including Zoloft, Prozac and Lexapro, though HHS spokesman Andrew Nixon denied any talks about banning SSRIs.
Kennedy on Monday instead announced measures to curb use, including doctor reimbursement for tapering patients, prescribing-data sharing and provider training, while saying patients should not stop medication.
About one in six US adults take SSRIs, which psychiatrists consider first-line depression treatment; regulatory experts said the FDA cannot ban approved drugs without strong new safety evidence.
How will patients be protected from the severe, long-term withdrawal symptoms from antidepressants that doctors often underestimate?
With the 'chemical imbalance' theory disproven, what science-backed alternatives to antidepressants will officials now prioritize for mental health treatment?
As gut health's link to depression emerges, will new policies favor microbial therapies over traditional psychiatric medications?